The global continuous glucose monitoring systems market size reached US$ 6.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032. More Info:- https://www.imarcgroup.com/continuous-glucose-monitoring-systems-market

1. Global Continuous
Glucose Monitoring
Systems Market Research
and Forecast Report
2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Continuous Glucose
Monitoring Systems Market: Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2024-2032," the global continuous glucose
monitoring systems market size reached US$ 6.7 Billion in 2023.
Continuous glucose monitoring systems (CGMS) are medical devices that track
blood glucose levels throughout the day using small sensors inserted under the
skin. They consist of sensors, transmitters, and receivers to collect, measure,
and display glucose level data. CGMS aid in monitoring glucose trends over
time by providing valuable information at crucial points, such as before and
during exercise and in the middle of the night.
These devices also offer a complete diabetes profile, detect patterns, and
evaluate and measure the effects of diet, medications, and physical activity on
sugar levels, thus reducing the chances of hypo/hyperglycemia . As compared
to conventional glucose monitoring machines, CGMS are painless and minimize
the number of finger-prick tests, as it uses interstitial fluid to measure glucose
levels instead of blood.
Request for a PDF sample of this report:
https://www.imarcgroup.com/continuous -glucose-monitoring-systems-
market/requestsample

4. Report Description
Global Continuous Glucose Monitoring Systems Market Trends:
The rising prevalence of diabetes due to sedentary lifestyles and obesity is one of the primary factors driving the
market growth. CGMS is widely used to track glucose levels in real-time, which aids in determining the
effectiveness of treatment plans and allows patients to make more informed decisions regarding physical activity,
a balanced diet, and medications. Furthermore, rising product adoption among patients using intensive insulin
therapy to improve glycemic control, reduce the occurrence of hypoglycemia events, and assist in tailoring the
insulin doses to improve hemoglobin A1c (HbA1c) levels is creating a positive outlook for the market.
Additionally, the integration of artificial intelligence (AI) to develop a decision support system that provides
advanced diabetes management through personalized insulin bolus calculation, adaptive tuning of bolus calculator
parameters, and glucose prediction is providing an impetus to the market growth. Moreover, the implementation of
various government initiatives to manage diabetes at a larger scale and spread awareness regarding preventive
care measure is facilitating the market growth. Other factors, including rising health consciousness among
consumers, extensive research and development (R&D) activities, and easy product availability across various e-
commerce platforms, are anticipated to drive the market growth.
Looking forward, the market is expected to reach US$ 10.2 Billion by 2032, exhibiting a CAGR of 5% during
2024-2032.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/continuous-glucose-monitoring-
systems-market

5. Report
Segmentation
Breakup by Component:
• Sensors
• Transmitters and Receivers
• Integrated Insulin Pumps
Breakup by Demographics:
• Child Population (≤14 years)
• Adult Population (>14 years)
Breakup by End User:
• Clinics and Diagnostics Centers
• ICUs

6. Report
Segmentation
• Home Healthcare
Breakup by Region:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• A. Menarini Diagnostics S.r.l.
• Abbott Laboratories
• DexCom Inc.
• F. Hoffmann-La Roche AG
• Glysens Incorporated
• LifeScan Inc. (Johnson & Johnson)
• Medtronic PLC
• Medtrum Technologies Inc.
• Nemaura Medical Inc.
• Novo Nordisk A/S
• Senseonics Holdings Inc.
• Waveform Technologies Inc.

8. Key Questions
Answered in
the Report
What was the size of the global continuous glucose monitoring
systems market in 2023?
What is the expected growth rate of the global continuous glucose
monitoring systems market during 2024-2032?
What has been the impact of COVID-19 on the global continuous
glucose monitoring systems market?
What are the key factors driving the global continuous glucose
monitoring systems market?
What is the breakup of the global continuous glucose monitoring
systems market based on the component?
What is the breakup of the global continuous glucose monitoring
systems market based on the demographics?
What is the breakup of the global continuous glucose monitoring
systems market based on end user?
What are the key regions in the global continuous glucose
monitoring systems market?
Who are the key players/companies in the global continuous
glucose monitoring systems market?

9. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Continuous Glucose Monitoring Systems
Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Sensors
6.1.1 Mark et T rends
6.1.2 Mark et Forecast
6.2 Transmitters and Receivers
6.2.1 Mark et T rends
6.2.2 Mark et Forecast
6.3 Integrated Insulin Pumps
6.3.1 Mark et T rends
6.3.2 Mark et Forecast
7 Market Breakup by Demographics

10. Table of
Contents
7.1 Child Population ( ≤14 years)
7.1.1 Mark et Trends
7.1.2 Mark et Forecast
7.2 Adult Population (> 14 years)
7.2.1 Mark et Trends
7.2.2 Mark et Forecast
8 Market Breakup by End User
8.1 Clinics and Diagnostics Centers
8.1.1 Mark et Trends
8.1.2 Mark et Forecast
8.2 ICUs
8.2.1 Mark et Trends
8.2.2 Mark et Forecast
8.3 Home Healthcare
8.3.1 Mark et Trends
8.3.2 Mark et Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Mark et Trends
9.1.1.2 Mark et Forecast
9.1.2 Canada
9.1.2.1 Mark et Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Mark et Trends
9.2.1.2 Mark et Forecast
For more information, visit :
https://www.imarcgroup.com/continuous -glucose-monitoring-
systems-market/toc

11. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

12. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com